VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
+45
New
-17
Exited
117
Positions
| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Apr 2024 | 4,939,757 | -447,589 | $4.44B | +5.5% | 11.62% | EC |
| 2 | AstraZeneca PLC | N/A | Apr 2024 | 16,923,322 | -58,576,678 | $2.42B | +3111.3% | 6.34% | EC |
| 3 | UnitedHealth Group Inc | 91324P102 | Apr 2024 | 5,718,685 | -574,797 | $2.35B | -22.7% | 6.15% | EC |
| 4 | Merck & Co Inc | 58933Y105 | Apr 2024 | 21,141,145 | +1,907,368 | $1.80B | -27.5% | 4.71% | EC |
| 5 | Vertex Pharmaceuticals Inc | 92532F100 | Apr 2024 | 2,758,647 | +955,869 | $1.41B | +98.5% | 3.68% | EC |
| 6 | Boston Scientific Corp | 101137107 | Apr 2024 | 13,510,582 | -246,672 | $1.39B | +40.6% | 3.64% | EC |
| 7 | Novartis AG | H5820Q150 | Apr 2024 | 10,670,181 | -6,370,484 | $1.22B | -26.4% | 3.18% | EC |
| 8 | Novo Nordisk A/S | N/A | Apr 2024 | 17,901,663 | New | $1.20B | — | 3.13% | EC |
| 9 | Edwards Lifesciences Corp | 28176E108 | Apr 2024 | 15,848,748 | +6,446,406 | $1.20B | +50.3% | 3.13% | EC |
| 10 | Abbott Laboratories | 002824100 | Apr 2024 | 8,381,425 | +625,685 | $1.10B | +33.3% | 2.87% | EC |
| 11 | Danaher Corp | 235851102 | Apr 2024 | 5,300,353 | +186,790 | $1.06B | -16.2% | 2.76% | EC |
| 12 | Argenx SE | N/A | Apr 2024 | 1,572,872 | New | $1.02B | — | 2.66% | EC |
| 13 | Intuitive Surgical Inc | 46120E602 | Apr 2024 | 1,882,202 | +206,684 | $970.8M | +56.3% | 2.54% | EC |
| 14 | Bristol-Myers Squibb Co | 110122108 | Apr 2025 | 17,248,970 | New | $865.9M | — | 2.26% | EC |
| 15 | Daiichi Sankyo Co Ltd | N/A | Apr 2024 | 31,579,497 | New | $807.8M | — | 2.11% | EC |
| 16 | GSK PLC | N/A | Apr 2024 | 36,708,771 | New | $726.2M | — | 1.90% | EC |
| 17 | UCB SA | B93562120 | Apr 2024 | 3,949,860 | -3,642,738 | $724.2M | -28.1% | 1.89% | EC |
| 18 | Biogen Inc | 09062X103 | Apr 2024 | 4,367,085 | -191,368 | $528.8M | -46.0% | 1.38% | EC |
| 19 | Cencora Inc | 03073E105 | Apr 2024 | 1,777,329 | +136,083 | $520.2M | +32.6% | 1.36% | EC |
| 20 | Alnylam Pharmaceuticals Inc | 02043Q107 | Apr 2024 | 1,959,156 | -3,584,152 | $515.7M | -35.4% | 1.35% | EC |
| 21 | HCA Healthcare Inc | 40412C101 | Apr 2024 | 1,477,327 | -1,171,216 | $509.8M | -37.9% | 1.33% | EC |
| 22 | Galderma Group AG | N/A | Apr 2024 | 4,311,231 | New | $500.7M | — | 1.31% | EC |
| 23 | Thermo Fisher Scientific Inc | 883556102 | Apr 2024 | 1,088,992 | -1,019,142 | $467.2M | -61.0% | 1.22% | EC |
| 24 | Chugai Pharmaceutical Co Ltd | N/A | Apr 2024 | 7,886,142 | New | $454.3M | — | 1.19% | EC |
| 25 | Elevance Health Inc | 036752103 | Apr 2024 | 1,070,559 | -1,065,526 | $450.3M | -60.1% | 1.18% | EC |
| 26 | Eisai Co Ltd | N/A | Apr 2024 | 14,823,917 | New | $428.5M | — | 1.12% | EC |
| 27 | Humana Inc | 444859102 | Apr 2024 | 1,452,691 | -811,401 | $381.0M | -44.3% | 1.00% | EC |
| 28 | Agilent Technologies Inc | 00846U101 | Apr 2024 | 3,319,724 | +66,583 | $357.2M | -19.9% | 0.93% | EC |
| 29 | Otsuka Holdings Co Ltd | N/A | Apr 2024 | 7,116,100 | New | $346.9M | — | 0.91% | EC |
| 30 | Charles River Laboratories International Inc | 159864107 | Apr 2025 | 2,541,219 | New | $301.4M | — | 0.79% | EC |
| 31 | Astellas Pharma Inc | N/A | Apr 2024 | 28,558,578 | New | $286.0M | — | 0.75% | EC |
| 32 | Molina Healthcare Inc | 60855R100 | Apr 2024 | 873,708 | +24,434 | $285.7M | -1.7% | 0.75% | EC |
| 33 | Exact Sciences Corp | 30063P105 | Apr 2024 | 6,061,109 | +3,403,872 | $276.6M | +75.4% | 0.72% | EC |
| 34 | United Therapeutics Corp | 91307C102 | Apr 2024 | 910,860 | +68,267 | $276.1M | +39.8% | 0.72% | EC |
| 35 | Align Technology Inc | 016255101 | Apr 2024 | 1,578,738 | +1,017,107 | $273.6M | +72.5% | 0.72% | EC |
| 36 | Genmab A/S | N/A | Apr 2024 | 1,260,164 | New | $267.2M | — | 0.70% | EC |
| 37 | Centene Corp | 15135B101 | Apr 2024 | 4,264,440 | -4,343,479 | $255.2M | -59.4% | 0.67% | EC |
| 38 | Terumo Corp | J83173104 | Apr 2024 | 12,871,400 | -1,081,400 | $246.4M | +4.1% | 0.64% | EC |
| 39 | Pfizer Inc | 717081103 | Apr 2024 | 8,900,488 | -36,123,217 | $217.3M | -81.2% | 0.57% | EC |
| 40 | QIAGEN NV | N72482149 | Apr 2024 | 4,977,756 | +3,890,994 | $212.8M | +362.6% | 0.56% | EC |
| 41 | Denali Therapeutics Inc | 24823R105 | Apr 2024 | 10,727,885 | +3,053,161 | $178.6M | +50.7% | 0.47% | EC |
| 42 | Apellis Pharmaceuticals Inc | 03753U106 | Apr 2024 | 9,286,573 | -216,802 | $178.4M | -57.5% | 0.47% | EC |
| 43 | Option Care Health Inc | 68404L201 | Apr 2024 | 5,476,256 | +1,369,183 | $176.9M | +44.1% | 0.46% | EC |
| 44 | Ionis Pharmaceuticals Inc | 462222100 | Apr 2024 | 5,733,312 | +2,141,632 | $176.1M | +18.8% | 0.46% | EC |
| 45 | Cytokinetics Inc | 23282W605 | Apr 2024 | 4,067,922 | +2,598,367 | $174.3M | +93.4% | 0.46% | EC |
| 46 | REVOLUTION Medicines Inc | 76155X100 | Apr 2024 | 4,303,500 | -2,237,077 | $173.8M | -28.7% | 0.45% | EC |
| 47 | Labcorp Holdings Inc | 504922105 | Apr 2025 | 704,816 | New | $169.9M | — | 0.44% | EC |
| 48 | Akero Therapeutics Inc | 00973Y108 | Apr 2024 | 3,657,502 | +2,114,467 | $166.8M | +443.5% | 0.44% | EC |
| 49 | Amicus Therapeutics Inc | 03152W109 | Apr 2024 | 20,893,978 | +7,121,602 | $160.5M | +16.6% | 0.42% | EC |
| 50 | PTC Therapeutics Inc | 69366J200 | Apr 2024 | 3,182,387 | -211,476 | $158.6M | +45.4% | 0.41% | EC |
| 51 | Vaxcyte Inc | 92243G108 | Apr 2024 | 4,275,884 | +1,641,951 | $153.2M | -3.9% | 0.40% | EC |
| 52 | Immunocore Holdings PLC | N/A | Apr 2024 | 4,582,598 | New | $137.9M | — | 0.36% | EC |
| 53 | Sarepta Therapeutics Inc | 803607100 | Apr 2024 | 2,112,434 | +198,198 | $131.8M | -45.6% | 0.34% | EC |
| 54 | Acadia Healthcare Co Inc | 00404A109 | Apr 2024 | 5,568,412 | +1,910,366 | $130.3M | -51.8% | 0.34% | EC |
| 55 | Blueprint Medicines Corp | 09627Y109 | Apr 2024 | 1,362,970 | -786,677 | $122.0M | -37.9% | 0.32% | EC |
| 56 | Structure Therapeutics Inc | N/A | Apr 2024 | 4,414,573 | New | $119.2M | — | 0.31% | EC |
| 57 | Encompass Health Corp | 29261A100 | Apr 2024 | 1,018,140 | -1,077,733 | $119.1M | -31.8% | 0.31% | EC |
| 58 | Merus NV | N5749R100 | Apr 2025 | 2,564,840 | New | $116.7M | — | 0.31% | EC |
| 59 | Natixis SA | N/A | Apr 2024 | 108,400,000 | New | $108.4M | — | 0.28% | RA |
| 60 | Kymera Therapeutics Inc | 501575104 | Apr 2024 | 3,013,587 | +1,566,823 | $103.3M | +112.3% | 0.27% | EC |
| 61 | Apogee Therapeutics Inc | 03770N101 | Apr 2024 | 2,605,583 | +1,470,473 | $102.3M | +79.1% | 0.27% | EC |
| 62 | BNP Paribas Securities Corp. | N/A | Apr 2024 | 101,800,000 | New | $101.8M | — | 0.27% | RA |
| 63 | Surgery Partners Inc | 86881A100 | Apr 2024 | 4,602,252 | +992,414 | $101.0M | +12.2% | 0.26% | EC |
| 64 | Avidity Biosciences Inc | 05370A108 | Apr 2025 | 3,030,557 | New | $98.9M | — | 0.26% | EC |
| 65 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 2,542,337 | — | $97.1M | -6.0% | 0.25% | EC |
| 66 | Glaukos Corp | 377322102 | Apr 2025 | 1,022,684 | New | $96.4M | — | 0.25% | EC |
| 67 | Celldex Therapeutics Inc | 15117B202 | Apr 2024 | 4,548,457 | +1,179,141 | $94.7M | -24.9% | 0.25% | EC |
| 68 | Zai Lab Ltd | N/A | Apr 2024 | 29,739,200 | New | $94.7M | — | 0.25% | EC |
| 69 | JP Morgan Securities LLC | N/A | Apr 2024 | 85,000,000 | New | $85.0M | — | 0.22% | RA |
| 70 | Moderna Inc | 60770K107 | Apr 2024 | 2,831,156 | -1,785,266 | $80.8M | -84.1% | 0.21% | EC |
| 71 | Crinetics Pharmaceuticals Inc | 22663K107 | Apr 2025 | 2,284,367 | New | $76.3M | — | 0.20% | EC |
| 72 | Evolent Health Inc | 30050B101 | Apr 2024 | 6,778,267 | +3,426,648 | $66.8M | -28.1% | 0.17% | EC |
| 73 | Guardant Health Inc | 40131M109 | Apr 2025 | 1,407,827 | New | $66.5M | — | 0.17% | EC |
| 74 | Bank of America Securities, LLC | N/A | Apr 2024 | 65,700,000 | New | $65.7M | — | 0.17% | RA |
| 75 | HSBC Bank USA | N/A | Apr 2024 | 65,400,000 | New | $65.4M | — | 0.17% | RA |
| 76 | Credit Agricole | N/A | Apr 2024 | 63,200,000 | New | $63.2M | — | 0.17% | RA |
| 77 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | N/A | Apr 2024 | 620,363 | New | $62.0M | — | 0.16% | STIV |
| 78 | Tecan Group AG | N/A | Apr 2024 | 314,428 | New | $61.2M | — | 0.16% | EC |
| 79 | Shandong Weigao Group Medical Polymer Co Ltd | N/A | Apr 2024 | 77,092,000 | New | $56.7M | — | 0.15% | EC |
| 80 | Legend Biotech Corp | N/A | Apr 2024 | 1,437,205 | New | $50.2M | — | 0.13% | EC |
| 81 | Alkermes PLC | G01767105 | Apr 2024 | 1,652,004 | -6,949,888 | $47.5M | -77.5% | 0.12% | EC |
| 82 | Genus PLC | G3827X105 | Apr 2024 | 1,791,160 | — | $44.0M | +9.3% | 0.12% | EC |
| 83 | PACS Group Inc | 69380Q107 | Apr 2024 | 4,425,093 | +2,589,188 | $42.6M | -7.0% | 0.11% | EC |
| 84 | Newamsterdam Pharma Co NV | N/A | Apr 2024 | 2,156,406 | New | $41.3M | — | 0.11% | EC |
| 85 | Nuvalent Inc | 670703107 | Apr 2025 | 534,465 | New | $41.0M | — | 0.11% | EC |
| 86 | Prothena Corp PLC | G72800108 | Apr 2024 | 4,183,812 | +1,789,549 | $38.5M | -21.0% | 0.10% | EC |
| 87 | Disc Medicine Inc | 254604101 | Apr 2025 | 719,845 | New | $35.6M | — | 0.09% | EC |
| 88 | Bank of Nova Scotia | N/A | Apr 2024 | 35,100,000 | New | $35.1M | — | 0.09% | RA |
| 89 | Rocket Pharmaceuticals Inc | 77313F106 | Apr 2024 | 4,332,967 | -580,153 | $33.1M | -68.7% | 0.09% | EC |
| 90 | HSBC Bank USA | N/A | Apr 2024 | 30,800,000 | New | $30.8M | — | 0.08% | RA |
| 91 | Autolus Therapeutics PLC | N/A | Apr 2024 | 19,356,365 | New | $27.3M | — | 0.07% | EC |
| 92 | Nomura Securities International, Inc. | N/A | Apr 2024 | 24,800,000 | New | $24.8M | — | 0.06% | RA |
| 93 | Barclays Capital Inc. | N/A | Apr 2024 | 24,200,000 | New | $24.2M | — | 0.06% | RA |
| 94 | Zai Lab Ltd | N/A | Apr 2024 | 700,766 | New | $22.2M | — | 0.06% | EC |
| 95 | BNP Paribas Securities Corp. | N/A | Apr 2024 | 21,100,000 | New | $21.1M | — | 0.06% | RA |
| 96 | Bank of America Securities, LLC | N/A | Apr 2024 | 20,000,000 | New | $20.0M | — | 0.05% | RA |
| 97 | RBC Capital Markets LLC | N/A | Apr 2024 | 18,100,000 | New | $18.1M | — | 0.05% | RA |
| 98 | Nomura Securities International, Inc. | N/A | Apr 2024 | 15,000,000 | New | $15.0M | — | 0.04% | RA |
| 99 | Metsera Inc | 59267L107 | Apr 2025 | 338,900 | New | $8.2M | — | 0.02% | EC |
| 100 | Hapvida Participacoes e Investimentos S/A | P5R526106 | Apr 2024 | 8,909,471 | — | $3.6M | -42.5% | 0.01% | EC |
| ✕ | Novo Nordisk A/S | K72807132 | — | 8,412,411 | Exited | $1078.8M | — | — | — |
| ✕ | Zoetis Inc | 98978V103 | — | 5,091,415 | Exited | $810.8M | — | — | — |
| ✕ | Stryker Corp | 863667101 | — | 2,022,549 | Exited | $680.6M | — | — | — |
| ✕ | Regeneron Pharmaceuticals Inc | 75886F107 | — | 675,638 | Exited | $601.8M | — | — | — |
| ✕ | IQVIA Holdings Inc | 46266C105 | — | 1,600,147 | Exited | $370.9M | — | — | — |
| ✕ | Laboratory Corp of America Holdings | 50540R409 | — | 1,381,908 | Exited | $278.3M | — | — | — |
| ✕ | Insulet Corp | 45784P101 | — | 1,457,112 | Exited | $250.5M | — | — | — |
| ✕ | Waters Corp | 941848103 | — | 666,877 | Exited | $206.1M | — | — | — |
| ✕ | agilon health Inc | 00857U107 | — | 34,720,760 | Exited | $191.0M | — | — | — |
| ✕ | Teleflex Inc | 879369106 | — | 714,618 | Exited | $149.2M | — | — | — |
| ✕ | Syndax Pharmaceuticals Inc | 87164F105 | — | 4,249,352 | Exited | $89.8M | — | — | — |
| ✕ | Intellia Therapeutics Inc | 45826J105 | — | 3,296,787 | Exited | $70.6M | — | — | — |
| ✕ | Privia Health Group Inc | 74276R102 | — | 3,229,900 | Exited | $59.4M | — | — | — |
| ✕ | DiaSorin SpA | T3475Y104 | — | 552,359 | Exited | $55.8M | — | — | — |
| ✕ | Morphic Holding Inc | 61775R105 | — | 1,927,084 | Exited | $52.6M | — | — | — |
| ✕ | TG Therapeutics Inc | 88322Q108 | — | 3,066,304 | Exited | $41.9M | — | — | — |
| ✕ | Sage Therapeutics Inc | 78667J108 | — | 2,859,637 | Exited | $39.9M | — | — | — |